Stockhub

PlexBio Co., Ltd.

Page Discussion
Revision as of 00:39, 27 September 2022 by 95.149.241.133 (talk) (Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers automated DNA and RNA sample preparation extraction kits; IntelliPlex platform that is designed for precision image code MicroDisc (pCode) technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-Co...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Summary[1]Edit

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers automated DNA and RNA sample preparation extraction kits; IntelliPlex platform that is designed for precision image code MicroDisc (pCode) technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.

References and notesEdit

  1. ↑ Source: Yahoo Finance.
Retrieved from ‘https://stockhub.co/index.php?title=PlexBio_Co.,_Ltd.&oldid=77317’